Navigation Links
50,000 Potassium Iodide Pills Donated to Japan
Date:3/15/2011

MOORESVILLE, N.C., March 15, 2011 /PRNewswire/ -- Approximately 50,000 potassium iodide tablets have been donated by Nukepills.com to Tokushukai Hospital in Tokyo, Japan for immediate distribution to those affected by Japan's nuclear reactor crisis. This effort was facilitated by Dr. Alisa Suzuki Han, Radiologist at Brigham and Women's Hospital, a teaching facility of Harvard Medical School, in Boston, MA. The radiation-blocking drug, currently en route to Japan, will be distributed by the Tokushukai Medical Aid Team. "We are very pleased that these tablets will be given to people directly affected by the nuclear crisis," stated Troy Jones, President of Nukepills.com. "The efforts of Dr. Han and the Tokushukai Medical Aid Team are a wonderful example of professionals coming together to ensure the health and livelihood of those most in need."

Stockpiling of potassium iodide is recommended by health officials worldwide to prevent thyroid cancer of those exposed to radioactive iodine in the event of a nuclear reactor accident or detonation of a nuclear bomb. FDA approved in 1982, potassium iodide is available without a prescription. More information about FDA approved potassium iodide can be found online at http://www.nukepills.com.

Nukepills.com, celebrating its 12th year in business, is an Internet-based supplier of radiation emergency preparedness products that protect against dirty bomb radiation, nuclear reactor accidents and nuclear weapon fallout, and are used for radiation therapy/decontamination in hospitals. The company was founded in 1999 as a means of supplying FDA approved Iosat(TM) Potassium Iodide directly to the general public and now has international sales programs throughout Canada, Europe, Asia and the Middle East. In early 2009, Nukepills.com sold 5.4 million doses of FDA approved ThyroShield(TM) Liquid Potassium Iodide to Kuwait's Ministry of Health and expects Government Emergency Preparedness grants and civilian orders to continue to drive sales of all of its products well into 2011.

Logo: http://www.ereleases.com/pic/Nukepills-logo.jpg Contact: Troy Jones, President, Nukepills.comPh: 866-283-3986info@nukepills.com 631 Brawley School Rd STE 407Mooresville, NC 28117http://www.nukepills.com Twitter: http://twitter.com/nukepills This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Nukepills.com
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Will Rogers Institute Awards Top Doctor $50,000 for Outstanding Contributions to Lung Research
2. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
3. $250,000 Awarded to Smartfield, Inc. of Lubbock, TX by the Texas Emerging Technology Fund
4. BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts
5. Intralink-Spine Inc. Awarded $750,000 Small Business Innovation Research Phase II Grant
6. March of Dimes Awards $250,000 Prize to Scientist Who Discovered How to Reprogram Human Cells
7. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
8. Collexis BiomedExperts Fast Approaching 150,000 Registered Users
9. ZINO Society Spurring Investments, 12 Life Sciences Companies to Vie for $50,000 ZINO Life Fund
10. Huntington Area Development Council Attracts Technology-Based Startup Companies With $150,000 Grant From Verizon West Virginia
11. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift ... new partnership with Compass Research . GGI's mission is to advance global health ... a child in need in honor of each clinical trial volunteer. The vision of ...
(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
Breaking Biology Technology:
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):